IE66500B1 - Method for increasing enzyme activities and synthesis performance of organisms - Google Patents
Method for increasing enzyme activities and synthesis performance of organismsInfo
- Publication number
- IE66500B1 IE66500B1 IE7989A IE7989A IE66500B1 IE 66500 B1 IE66500 B1 IE 66500B1 IE 7989 A IE7989 A IE 7989A IE 7989 A IE7989 A IE 7989A IE 66500 B1 IE66500 B1 IE 66500B1
- Authority
- IE
- Ireland
- Prior art keywords
- microorganisms
- elicitor
- same
- bacteria
- atcc
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title claims abstract description 33
- 238000000034 method Methods 0.000 title claims abstract description 21
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 20
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 20
- 238000003786 synthesis reaction Methods 0.000 title claims abstract description 14
- 230000000694 effects Effects 0.000 title claims description 22
- 244000005700 microbiome Species 0.000 claims abstract description 62
- 239000005712 elicitor Substances 0.000 claims abstract description 41
- 241000894006 Bacteria Species 0.000 claims abstract description 24
- 239000012634 fragment Substances 0.000 claims abstract description 17
- 229930013930 alkaloid Natural products 0.000 claims abstract description 10
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 8
- 229940088710 antibiotic agent Drugs 0.000 claims abstract description 8
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000000280 phytoalexin Substances 0.000 claims abstract description 7
- 150000001857 phytoalexin derivatives Chemical class 0.000 claims abstract description 7
- 241000196324 Embryophyta Species 0.000 claims description 20
- 230000028327 secretion Effects 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 230000002708 enhancing effect Effects 0.000 claims description 10
- 239000000975 dye Substances 0.000 claims description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 7
- 241000233866 Fungi Species 0.000 claims description 5
- 150000003797 alkaloid derivatives Chemical class 0.000 claims description 5
- 238000004113 cell culture Methods 0.000 claims description 3
- PYIXHKGTJKCVBJ-UHFFFAOYSA-N Astraciceran Natural products C1OC2=CC(O)=CC=C2CC1C1=CC(OCO2)=C2C=C1OC PYIXHKGTJKCVBJ-UHFFFAOYSA-N 0.000 claims 1
- NDVRQFZUJRMKKP-UHFFFAOYSA-N Betavulgarin Natural products O=C1C=2C(OC)=C3OCOC3=CC=2OC=C1C1=CC=CC=C1O NDVRQFZUJRMKKP-UHFFFAOYSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 abstract description 7
- 150000003431 steroids Chemical class 0.000 abstract description 6
- 230000008569 process Effects 0.000 abstract description 4
- 230000029142 excretion Effects 0.000 abstract 2
- 239000000049 pigment Substances 0.000 abstract 1
- 230000001131 transforming effect Effects 0.000 abstract 1
- 210000002421 cell wall Anatomy 0.000 description 23
- 210000004027 cell Anatomy 0.000 description 20
- 230000000638 stimulation Effects 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 229940088598 enzyme Drugs 0.000 description 12
- 238000007792 addition Methods 0.000 description 11
- 241000186216 Corynebacterium Species 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000000855 fermentation Methods 0.000 description 9
- 230000004151 fermentation Effects 0.000 description 9
- 239000000284 extract Substances 0.000 description 8
- 239000002609 medium Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
- -1 bibenzyls Chemical class 0.000 description 6
- 229960001031 glucose Drugs 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- VTIKDEXOEJDMJP-UHFFFAOYSA-N Actinorhodine Natural products CC1OC(CC(=O)O)CC2=C1C(=O)c3c(O)c(cc(O)c3C2=O)c4cc(O)c5C(=O)C6=C(C(C)OC(CC(=O)O)C6)C(=O)c5c4O VTIKDEXOEJDMJP-UHFFFAOYSA-N 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- 241000186146 Brevibacterium Species 0.000 description 5
- HCOLPNRPCMFHOH-UHFFFAOYSA-N Prodigiosin Natural products CCCCCC1C=C(C=C/2N=C(C=C2OC)c3ccc[nH]3)N=C1C HCOLPNRPCMFHOH-UHFFFAOYSA-N 0.000 description 5
- 241000187694 Rhodococcus fascians Species 0.000 description 5
- VTIKDEXOEJDMJP-WYUUTHIRSA-N actinorhodin Chemical compound C([C@@H](CC(O)=O)O[C@@H]1C)C(C(C2=C(O)C=3)=O)=C1C(=O)C2=C(O)C=3C(C(=C1C2=O)O)=CC(O)=C1C(=O)C1=C2[C@@H](C)O[C@H](CC(O)=O)C1 VTIKDEXOEJDMJP-WYUUTHIRSA-N 0.000 description 5
- 229940041514 candida albicans extract Drugs 0.000 description 5
- 206010013023 diphtheria Diseases 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- TWFGRJUTAULJPZ-USZBIXTISA-N prodigiosin Chemical compound N1=C(C)C(CCCCC)=C\C1=C/C1=NC(C=2[N]C=CC=2)=C[C]1OC TWFGRJUTAULJPZ-USZBIXTISA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 239000012138 yeast extract Substances 0.000 description 5
- 241000124224 Claviceps paspali Species 0.000 description 4
- 241000186226 Corynebacterium glutamicum Species 0.000 description 4
- 241000187398 Streptomyces lividans Species 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- GENAHGKEFJLNJB-QMTHXVAHSA-N lysergamide Chemical compound C1=CC(C2=C[C@H](CN([C@@H]2C2)C)C(N)=O)=C3C2=CNC3=C1 GENAHGKEFJLNJB-QMTHXVAHSA-N 0.000 description 4
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 4
- 235000019796 monopotassium phosphate Nutrition 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 4
- 241000193422 Bacillus lentus Species 0.000 description 3
- 229930186147 Cephalosporin Natural products 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- 241000187433 Streptomyces clavuligerus Species 0.000 description 3
- 241000187217 Streptomyces griseoruber Species 0.000 description 3
- 241000319304 [Brevibacterium] flavum Species 0.000 description 3
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 3
- 229940124587 cephalosporin Drugs 0.000 description 3
- 150000001780 cephalosporins Chemical class 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 3
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 229960001866 silicon dioxide Drugs 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 238000000844 transformation Methods 0.000 description 3
- GENAHGKEFJLNJB-IINYFYTJSA-N (6ar,9s)-7-methyl-6,6a,8,9-tetrahydro-4h-indolo[4,3-fg]quinoline-9-carboxamide Chemical compound C1=CC(C2=C[C@@H](CN([C@@H]2C2)C)C(N)=O)=C3C2=CNC3=C1 GENAHGKEFJLNJB-IINYFYTJSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 241000186145 Corynebacterium ammoniagenes Species 0.000 description 2
- 241000186247 Corynebacterium nephridii Species 0.000 description 2
- 241001070171 Corynebacterium striatum ATCC 6940 Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 244000001381 Eschscholzia californica Species 0.000 description 2
- DXVYLFHTJZWTRF-UHFFFAOYSA-N Ethyl isobutyl ketone Chemical compound CCC(=O)CC(C)C DXVYLFHTJZWTRF-UHFFFAOYSA-N 0.000 description 2
- ZAGRKAFMISFKIO-UHFFFAOYSA-N Isolysergic acid Natural products C1=CC(C2=CC(CN(C2C2)C)C(O)=O)=C3C2=CNC3=C1 ZAGRKAFMISFKIO-UHFFFAOYSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 108010059820 Polygalacturonase Proteins 0.000 description 2
- 244000061121 Rauvolfia serpentina Species 0.000 description 2
- 241000223253 Rhodotorula glutinis Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- INVGWHRKADIJHF-UHFFFAOYSA-N Sanguinarin Chemical compound C1=C2OCOC2=CC2=C3[N+](C)=CC4=C(OCO5)C5=CC=C4C3=CC=C21 INVGWHRKADIJHF-UHFFFAOYSA-N 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241000187747 Streptomyces Species 0.000 description 2
- 241001446311 Streptomyces coelicolor A3(2) Species 0.000 description 2
- 241000187410 Streptomyces purpurascens Species 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 241000204063 Tsukamurella paurometabola Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 239000001166 ammonium sulphate Substances 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229960002713 calcium chloride Drugs 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 210000003850 cellular structure Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 108010093305 exopolygalacturonase Proteins 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- OSVMTWJCGUFAOD-KZQROQTASA-N formestane Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1O OSVMTWJCGUFAOD-KZQROQTASA-N 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 229930005303 indole alkaloid Natural products 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229940043265 methyl isobutyl ketone Drugs 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000001384 succinic acid Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- RJNCJTROKRDRBW-TZMCWYRMSA-N (6ar,10ar)-7-methyl-4,6,6a,7,8,10a-hexahydroindolo[4,3-fg]quinoline-7-ium-9-carboxylate Chemical compound C1=CC([C@H]2C=C(CN([C@@H]2C2)C)C(O)=O)=C3C2=CNC3=C1 RJNCJTROKRDRBW-TZMCWYRMSA-N 0.000 description 1
- ZAGRKAFMISFKIO-IINYFYTJSA-N (6ar,9s)-7-methyl-6,6a,8,9-tetrahydro-4h-indolo[4,3-fg]quinoline-9-carboxylic acid Chemical compound C1=CC(C2=C[C@@H](CN([C@@H]2C2)C)C(O)=O)=C3C2=CNC3=C1 ZAGRKAFMISFKIO-IINYFYTJSA-N 0.000 description 1
- AZVSIMOMNHTWRV-XUCMERPOSA-N (8s,9s,10r,13s,14s,17s)-10,13-dimethyl-17-propanoyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)CC)[C@@]1(C)CC2 AZVSIMOMNHTWRV-XUCMERPOSA-N 0.000 description 1
- WEEFNMFMNMASJY-UHFFFAOYSA-M 1,2-dimethoxy-12-methyl-[1,3]benzodioxolo[5,6-c]phenanthridin-12-ium;chloride Chemical compound [Cl-].C1=C2OCOC2=CC2=CC=C3C4=CC=C(OC)C(OC)=C4C=[N+](C)C3=C21 WEEFNMFMNMASJY-UHFFFAOYSA-M 0.000 description 1
- PZASAAIJIFDWSB-CKPDSHCKSA-N 8-[(1S)-1-[8-(trifluoromethyl)-7-[4-(trifluoromethyl)cyclohexyl]oxynaphthalen-2-yl]ethyl]-8-azabicyclo[3.2.1]octane-3-carboxylic acid Chemical compound FC(F)(F)C=1C2=CC([C@@H](N3C4CCC3CC(C4)C(O)=O)C)=CC=C2C=CC=1OC1CCC(C(F)(F)F)CC1 PZASAAIJIFDWSB-CKPDSHCKSA-N 0.000 description 1
- XJOOMMHNYOJWCZ-UHFFFAOYSA-N Agroclavine Natural products C1=CC(C2C=C(C)CN(C2C2)C)=C3C2=CNC3=C1 XJOOMMHNYOJWCZ-UHFFFAOYSA-N 0.000 description 1
- 241000027112 Alternaria carthami Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 241001451492 Bacillus pumilus ATCC 7061 Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 244000177578 Bacterium linens Species 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- 241000186321 Cellulomonas Species 0.000 description 1
- LLEJIEBFSOEYIV-UHFFFAOYSA-N Chelerythrine Natural products C1=C2OCOC2=CC2=CC=C3C4=CC=C(OC)C(OC)=C4C=[N+](C)C3=C21 LLEJIEBFSOEYIV-UHFFFAOYSA-N 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 241000807905 Corynebacterium glutamicum ATCC 14067 Species 0.000 description 1
- 241000133018 Corynebacterium melassecola Species 0.000 description 1
- 241000186245 Corynebacterium xerosis Species 0.000 description 1
- 108010036941 Cyclosporins Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- RATMHCJTVBHJSU-UHFFFAOYSA-N Dihydrochelerythrine Natural products C1=C2OCOC2=CC2=C(N(C)C(O)C=3C4=CC=C(C=3OC)OC)C4=CC=C21 RATMHCJTVBHJSU-UHFFFAOYSA-N 0.000 description 1
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 description 1
- NESVMZOPWPCFAU-UHFFFAOYSA-N Ergoclavinine Natural products C1=CC(C=2C(N(C)CC(C=2)C(=O)NC2(C(=O)N3C(C(N4CCCC4C3(O)O2)=O)CC(C)C)C)C2)=C3C2=CNC3=C1 NESVMZOPWPCFAU-UHFFFAOYSA-N 0.000 description 1
- 241000588698 Erwinia Species 0.000 description 1
- FCEXWTOTHXCQCQ-UHFFFAOYSA-N Ethoxydihydrosanguinarine Natural products C12=CC=C3OCOC3=C2C(OCC)N(C)C(C2=C3)=C1C=CC2=CC1=C3OCO1 FCEXWTOTHXCQCQ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical class C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- IECPWNUMDGFDKC-UHFFFAOYSA-N Fusicsaeure Natural products C12C(O)CC3C(=C(CCC=C(C)C)C(O)=O)C(OC(C)=O)CC3(C)C1(C)CCC1C2(C)CCC(O)C1C IECPWNUMDGFDKC-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 108010026389 Gramicidin Proteins 0.000 description 1
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- SAHHMCVYMGARBT-UHFFFAOYSA-N Isochanoclavine I Natural products C1=CC(C(C(NC)C2)C=C(C)CO)=C3C2=CNC3=C1 SAHHMCVYMGARBT-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 108010059881 Lactase Proteins 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- JOCBASBOOFNAJA-UHFFFAOYSA-N N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid Chemical compound OCC(CO)(CO)NCCS(O)(=O)=O JOCBASBOOFNAJA-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 241000187580 Nocardioides Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 108010073038 Penicillin Amidase Proteins 0.000 description 1
- XVASOOUVMJAZNJ-MBNYWOFBSA-N Penicillin K Chemical compound S1C(C)(C)[C@H](C(O)=O)N2C(=O)[C@@H](NC(=O)CCCCCCC)[C@H]21 XVASOOUVMJAZNJ-MBNYWOFBSA-N 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 241000985516 Penicillium raistrickii Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000203722 Pimelobacter Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000187603 Pseudonocardia Species 0.000 description 1
- 241000635201 Pumilus Species 0.000 description 1
- VLMZMRDOMOGGFA-PSOPSSQASA-N Pyroclavine Natural products C1=CC([C@H]2C[C@@H](CN(C)[C@@H]2C2)C)=C3C2=CNC3=C1 VLMZMRDOMOGGFA-PSOPSSQASA-N 0.000 description 1
- 239000006004 Quartz sand Substances 0.000 description 1
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 1
- 241000223252 Rhodotorula Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000187175 Streptomyces violaceus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000007994 TES buffer Substances 0.000 description 1
- 241000866060 Terrabacter tumescens Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 108700040099 Xylose isomerases Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229930183665 actinomycin Natural products 0.000 description 1
- YDOTUXAWKBPQJW-UHFFFAOYSA-N alpha-Ergocryptinine Natural products C1=CC(C=2C(N(C)CC(C=2)C(=O)NC2(C(=O)N3C(C(N4CCCC4C3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=CNC3=C1 YDOTUXAWKBPQJW-UHFFFAOYSA-N 0.000 description 1
- YDOTUXAWKBPQJW-NSLWYYNWSA-N alpha-ergocryptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=CNC3=C1 YDOTUXAWKBPQJW-NSLWYYNWSA-N 0.000 description 1
- 229950001817 alpha-ergocryptine Drugs 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Chemical compound C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 description 1
- 229940052299 calcium chloride dihydrate Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- RNSBFHHWMMKJAM-UHFFFAOYSA-N chelirubine Chemical compound C12=C[N+](C)=C3C4=CC=5OCOC=5C=C4C=CC3=C2C(OC)=CC2=C1OCO2 RNSBFHHWMMKJAM-UHFFFAOYSA-N 0.000 description 1
- QRCWKBAFKDYSFR-UHFFFAOYSA-N chelirubine Natural products COc1cc2cc3OCOc3cc2c4N(C)C(O)c5c6OCOc6ccc5c14 QRCWKBAFKDYSFR-UHFFFAOYSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 150000001907 coumarones Chemical class 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- RJNCJTROKRDRBW-UHFFFAOYSA-N d-paspalic acid Natural products C1=CC(C2C=C(CN(C2C2)C)C(O)=O)=C3C2=CNC3=C1 RJNCJTROKRDRBW-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 238000001085 differential centrifugation Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- AJFXNBUVIBKWBT-UHFFFAOYSA-N disodium;boric acid;hydrogen borate Chemical compound [Na+].[Na+].OB(O)O.OB(O)O.OB(O)O.OB([O-])[O-] AJFXNBUVIBKWBT-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- OWEUDBYTKOYTAD-MKTPKCENSA-N ergocristine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](C(N21)=O)(NC(=O)[C@@H]1C=C2C3=CC=CC4=NC=C([C]34)C[C@H]2N(C)C1)C(C)C)C1=CC=CC=C1 OWEUDBYTKOYTAD-MKTPKCENSA-N 0.000 description 1
- HEFIYUQVAZFDEE-UHFFFAOYSA-N ergocristinine Natural products N12C(=O)C(C(C)C)(NC(=O)C3C=C4C=5C=CC=C6NC=C(C=56)CC4N(C)C3)OC2(O)C2CCCN2C(=O)C1CC1=CC=CC=C1 HEFIYUQVAZFDEE-UHFFFAOYSA-N 0.000 description 1
- NESVMZOPWPCFAU-ZPRCMDFASA-N ergosine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C)C2)=C3C2=CNC3=C1 NESVMZOPWPCFAU-ZPRCMDFASA-N 0.000 description 1
- 229960003133 ergot alkaloid Drugs 0.000 description 1
- OFKDAAIKGIBASY-VFGNJEKYSA-N ergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C3=CC=CC4=NC=C([C]34)C2)=C1)C)C1=CC=CC=C1 OFKDAAIKGIBASY-VFGNJEKYSA-N 0.000 description 1
- 229960004943 ergotamine Drugs 0.000 description 1
- XCGSFFUVFURLIX-UHFFFAOYSA-N ergotaminine Natural products C1=C(C=2C=CC=C3NC=C(C=23)C2)C2N(C)CC1C(=O)NC(C(N12)=O)(C)OC1(O)C1CCCN1C(=O)C2CC1=CC=CC=C1 XCGSFFUVFURLIX-UHFFFAOYSA-N 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 125000002534 ethynyl group Chemical class [H]C#C* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- VLMZMRDOMOGGFA-WDBKCZKBSA-N festuclavine Chemical compound C1=CC([C@H]2C[C@H](CN(C)[C@@H]2C2)C)=C3C2=CNC3=C1 VLMZMRDOMOGGFA-WDBKCZKBSA-N 0.000 description 1
- QOLIPNRNLBQTAU-UHFFFAOYSA-N flavan Chemical class C1CC2=CC=CC=C2OC1C1=CC=CC=C1 QOLIPNRNLBQTAU-UHFFFAOYSA-N 0.000 description 1
- 229960004675 fusidic acid Drugs 0.000 description 1
- IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical compound O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 description 1
- 229960002867 griseofulvin Drugs 0.000 description 1
- ZDPUTNZENXVHJC-UUOKFMHZSA-N guanosine 3'-monophosphate Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](OP(O)(O)=O)[C@H]1O ZDPUTNZENXVHJC-UUOKFMHZSA-N 0.000 description 1
- 235000013928 guanylic acid Nutrition 0.000 description 1
- 239000004226 guanylic acid Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- MIFYHUACUWQUKT-GTQWGBSQSA-N isopenicillin N Chemical compound OC(=O)[C@H]1C(C)(C)S[C@@H]2[C@H](NC(=O)CCC[C@H](N)C(O)=O)C(=O)N21 MIFYHUACUWQUKT-GTQWGBSQSA-N 0.000 description 1
- 229940116108 lactase Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- ZAGRKAFMISFKIO-QMTHXVAHSA-N lysergic acid Chemical compound C1=CC(C2=C[C@H](CN([C@@H]2C2)C)C(O)=O)=C3C2=CNC3=C1 ZAGRKAFMISFKIO-QMTHXVAHSA-N 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 235000002867 manganese chloride Nutrition 0.000 description 1
- 150000002731 mercury compounds Chemical class 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- XPGDBEXDXZQNFP-UHFFFAOYSA-N nitrate tetrahydrate Chemical compound O.O.O.O.[O-][N+]([O-])=O XPGDBEXDXZQNFP-UHFFFAOYSA-N 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 150000002987 phenanthrenes Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229940084560 sanguinarine Drugs 0.000 description 1
- YZRQUTZNTDAYPJ-UHFFFAOYSA-N sanguinarine pseudobase Natural products C1=C2OCOC2=CC2=C3N(C)C(O)C4=C(OCO5)C5=CC=C4C3=CC=C21 YZRQUTZNTDAYPJ-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 150000003432 sterols Chemical group 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 150000001629 stilbenes Chemical class 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 150000004685 tetrahydrates Chemical class 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/04—Plant cells or tissues
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Fertilizers (AREA)
Abstract
In the process disclosed, the organisms are brought into contact witn inactivated elicitor-containing microorganisms, fragments of the latter, or excretions of elicitor-containing microorganisms. Only inactivated elicitor-containing bacteria, fragments of the latter, or excretions of elicitor-containing bacteria may be used to activate enzymes and promote synthesis in non-microbial organisms. The process can be used, for example, to promote synthesis in microorganisms or plants which produce pigments, antibiotics, alkaloids or phytoalexins or to activate enzymes in microorganisms capable of transforming steroids.
Description
The invention relates to a method of enhancing enzyneactivities and the synthetic capacity of microorganismsand higher plants, which is characterised in that thesame are brought into contact with inactivated elicitor-containing microorganisms, fragments of the same orsecretions of elicitor-containing microorganisms, withthe proviso that, in order to enhance enzyne activitiesand the synthetic capacity of higher plants, inactivatedelicitor-containing bacteria, fragments of the same orsecretions of elicitor-containing bacteria are used.
As is known, elicitors are microbial or plant activeingredients which, when brought into contact withtissues of higher plants, enhance the latterfs enzyneactivities and synthetic capacity. The components soaccumulated in those plants are termed phytoalexins ifthey are antimicrobial (Naturwissenschaften, 58, 1981,447ff, Adv. Enzymol. 55 . 1983, Iff and Spektrum derWissenschaft U,, 1985, 85ff).
At present, more than 100 compounds that satisfy thedefinition of phytoalexins have been isolated fromvarious plant species. They belong to various groups ofnatural substances, such as terpenoids, linolanic acidderivatives, acetylenes and polyacetylenes, bibenzyls,stilbenes, phenanthrenes and dihydrophenanthrenes,benzofurans and phenolbenzofurans, furocumarins, avenalu-mines, flavans, phenvibenzofurans, benzoxazinones,alkaloids, isoflavonoids (Brooks and Watson, Nat. Prod.Reports 2, 1985, 427).
Hitherto, that elicitor action has not found any indus-trial application, for several reasons: with a few excep-tions, it has hitherto not been possible to propagatecells of higher plants in submerged cultures undereconomically acceptable conditions. A priori. it seemed 2 pointless to use elicitors in fermentation by means ofmicroorganisms because, on the basis of the prevailingexpert opinion regarding the mode of action of elicitors(Albersheim P. and Darvill A.G. Spektrua der wissen- 5 schaft, 11 1985 „ 85) it had to toe assumed that elicitors did not influence enzyme activity and the metabolicprocesses in microorganisms.
It should also be noted that, according to the acceptedexpert opinion, bacteria, for example representatives of 10 the genus Erwinia, can induce the formation of phyto- alexins in plants only by freeing elicitors (oligogalact-uronids) from the plant cell wall by means of specificenzymes (pectinases), which elicitors, as endogenouselicitors, stimulate the formation of phytoalexins. 15 it has now been found that compounds and cell prepara- tions of microorganisms, which are referred to in thefollowing as elicitors, are, after all, surprisinglycapable of enhancing enzyme activities in microorganismsand of enhancing the latter's synthetic capacity. In 20 addition, it has been found that there are also bacteria that contain elicitors that are not enzymes or nutritivefactors.
In principle, the method according to the invention canbe carried out by means of isolated or synthesised 25 elicitors, but that is generally far too complicated. It is sufficient to use inactivated elicitor-containing microorganisms, or fragments of those microorganisms,such as, for example, cell wall fractions, cell fragments of mechanically disrupted or chemically or enzymaticallylysed cells, or cell components precipitated by auxiliar-ies, such as, for example, ethanol or acetone. Inactiv-ated microorganisms within the context of the inventionare those which have lost their viability permanently.
If the microorganism releases elicitors into the culturemedium, or forms we ter-"soluble el icitor—containing cellcomponents after lysis or sterilisation, those elicitor-containing secretions of the microorganisms can also be 5 used to carry out the method according to the invention.
Any form of elxcxtor-containing product of microorganismsis suitable for carrying out the method according to theinvention.
Microorganisms that are known to possess elicitors are, 10 inter alia, the fungal strains and yeasts listed in thefollowing Table l: 4 ci ’S" Alternaria carthami Arch. Bioch. Biop. 229, 1984, 136 =-: en r- =3 rM Gt O' σ o «a. σ» A· CO n- co 03 m ♦"§ m vO *3 © ft» Gt r- fn «> Gt ·, «ft rt =-t - ¢-5 ·. (*» f·. o m A3 CO Gt Cft =4 n-3 in η- co σι CO Gt *—3 Θ «· ω ns σ» %* σ m Gt Gt (rt » ΟΊ o* rt & •®> ¢-4 61 rj M =4 m Gt η «-Μ Gt ft" =3 o n <· rM - 6Ί ra m eg n n m O "»31 03 03 ¢3 Gt 03 t-i «0 X? o 03 6¼ - p—3 ea «· co .-3 ft· ¢-3 G Θ Gt C9 f ί cat ο» os c« «. ft. σι e* «-Ι •ft F-a ¢-11 l". •0 3 > 44 © . a >i44 XS S3 >3 <«. O 44 Λ 8S3 » >44 O . a © G Is . G .G =4 & ;~5 c o Si © K rw Ss ϋ1 c .—.J © 3 <3 44 J.J O (3 o O « 44 (3 «2 . 44 &) © os . . © O (S - o cs O' ¢=3 c© 0 M o Ή CO e-Hl iU 6 ¢=3 £ »"9 JS *-3 ¢-3 ¢=3 O a •eH CO ft -rt m • •H o © «=3 • . a » O o o O 0.1 o «3 - 3 g 6 ca >*O g O «3 - © © · « £ a © « is a © © m . © -=» 4J · -m · © x o 0 Η X £ β H - ft. S-a xs i-3 s £S x; 3 ¢-8 £ (S © =-J eg =! a Is © ο a o 0 ο η η. o a >00000 a o a a - ®.o - ΰ O i - 44 o —! fij g Ο O (5 --5 Ο · Ο - O - (! 4.! CO ii u M · K . Q >, > >, > ts (S 3J >j >5 >j >, > >·) O > >i !-j (3 ϋ U x: x: £ · xs 3 ^ eg £*n. cl, & h a h e, 2 ¢. w b n " h & & < C-i κ i-- ft" nj in r-a η- © CJ —- © U na -ο in Γ- -=3 =-, —.· < σι =3 Γ- O CA ft· U n- ft· > —ft CO V0 ft· a n- ft- -, *ft^ ns Λ O' ε E-3 ns o' Λ3 10 in □ O < in o Gt ns ft" ft1 c o -»= e u Ut co R3 a e= © ^4 O σ> u •«a < ε u < > ft" s u £ •— 3 (S3 u © E-3 3 Ei 4J G U < © © o © S "C U f3 Φ < 3 -=i O O — vt Ξ W £ © -=4 3 — O 44 t.3 « ε U .Q > £ li E la C < © la &3 (S 3 0 ε © $4 © (3 -=3 © © © 0» © -=-3 44 © es£ ) a a "v ε 3 44 ©=-3 0 a o 4J a 44 a—3 > © © M 3 C a 44 (0 Ο Ο O (S3 -=3 ο ω o tn 44 0) © a -=a ej -H 3 > ϋ) , o >— © ks <3.1 3 ε <3-3 ε c c =4 C -=3 O 44 O o — s -=s ε c c la © Ό Φ 3 3 fO (S3 a·^ ka 3 © 0 0 CO ss ω ω Φ S £ r-9 =—j a o O la S Ο <3 © © © © © © la © ε ε -r4 —4 -H U 3 0 0 O (S3 a«-a φ 3 u b U la la h h 0 © 0 3 3 a 44 44 -=3 -=a οι ω 44 a Ua «3 .-a O © XS —a £ £ £ £ £ £ £ G =3 J w > > (0 o 44 K E E ¢-3 X 44 44 44 44 44 44 © © O ¢-3 =3 --CJ ϋ o a o 3 S u © 4J G, © βΧΧΛΛΧΛΧ •=3 p—i 44 o o ί-a W 44 -rt —a © £a GS a Ge Go Sd £Xa Qa £=d 3 © u o >a4J 44 Ό O (II 34 Ό Cl •Ή r—§ >>>>>,>, o (J li M O ffl ® £ ·-; o 3 3 (0 ¢-. Gl O © a a £ £ £ £ £ £ 3 > © © © ss a O U U u a a ϋ a s^saaaaaaaa0ia«i>> 5 In our own tests,, cell wall preparations„ purifiedproteolytically by trypsin, of gram-positive bacterialstrains of the genera Bacillus, Corynebacterium, Brevi-bacteriua, Cellulomonas, Lactobacillus, Pimelobacter,Rhodococcus and Staphylococcus and microorganisms ofthose genera heat-sterilised in water and the filtratesthereof were investigated to establish whether theypossess elicitors. Table 2 below lists the bacterialstrains in which elicitors were detected- Table 2 Bacillus licheniformis ATCC 9945 Bacillus pumilus ATCC 7061 Brevihacterxum toutanicum ATCC 21196 Brevibacterium flavum ATCC 13826, ATCC 14067 Brevibacterium lactofermentum ATCC 13655 Brevibacterium glutamingenes ATCC 13747 Brevibacterium ammaniagenes ATCC 6872 Corynebacterium hydrocarboc las turn ATCC 15592 Corynebacterium nephridii ATCC 114 25 CorynebacteriuM paurometabolum ATCC 8368 Corynebacteriuxa lilium ATCC 15990 Corynebacterium striatum ATCC 6940 Corynebacteriuxa xerosis ATCC 373 Corynebacterium diphtherias (strain Hass. 8/BehringWerke) Corynebacterium melassecola ATCC 17965 Corynebacteriuss glutamicum ATCC 13032 Corynebacterium uratoxidans ATCC 21749 Lactobacillus casei subsp. rhamnosus ATCC 7469 Lactobacillus plantarum DSM 20174 Pimelobacter tumescens AJ 1460 Rhodococcus fascians ATCC 12975 Rhodococcus fascians 1 - isolate of Prof. Or. Stolp,Univ. BayreuthRhodococcus fascians 2 -Univ. Bayreuth isolate of Prof. Or. Stolp,, In the context of the present invention, only bacterialstrains of a £@w genera of grass-positive eubacteria havehitherto been investigated to establish whether theypossess elicitors and, as far as can be established fromprior publications, of the fungal strains including theyeasts, generally only those which were known to bephytopathogenic have been investigated for the presenceof elicitor activities- It is therefore to be expectedthat a large number of other Microorganisms, such as, forexample, bacteria of the genera Mycobacterium, Nocardia,Nocardioides or Pseudonocardia, can also be found thatlikewise possess elicitors.
The examination of Microorganisms for elicitor activitycan be readily carried out by means of the usual screen-ing tests familiar to the person skilled in the art.
For example, in test series the microorganisms theenzyme activity or synthetic capacity of which is to beenhanced can be grown in submerged cultures, inactivatedmicroorganisms of different species or sub-species canbe added to the individual cultures and, when fermenta-tion is complete, it is possible to determine analyti-cally in which cultures enzyme activities or syntheticcapacity have been enhanced. An enhancement of themicroorganismss enzyme activities is recognised, forexample, by the fact that an increased rate of formation- or an increased yield - of process product is achievedin the fermentative conversion of substrates. According-ly, an enhanced synthetic capacity of the microorganismscan be recognised, for example, by an increased rate offormation - or an increased yield - of components of themicroorganism.
As shown by the tests carried out hitherto, which are 7 described in detail in the worked Examples, the methodaccording to the invention for enhancing enzyme activit-ies or the synthetic capacity of microorganisms seems tobe very versatile. For example, it was possible tostimulate the dyestuff formation of Streptomyces lividans(actinorhodin, prodigiosin) and the dyestuff formation ofStreptomyces coelicolor, Streptomyces griseoruber,Streptomyces latericius, Streptomyces purpurascens andStreptomyces violaceus by adding cell wall preparationsof microorganisms listed in Tabla 2. It was also possibleto stimulate the formation of S-lactam antibiotics ofStreptomyces clavuligerus and the alkaloid synthesis ofClaviceps paspali.
Such an enhancement of the synthetic capacity of micro-organisms can be achieved not only by means of the cellpreparations of the bacteria listed in Table 2 but it isto b® expected that an enhancement of enzyme activitiesand the synthetic capacity of microorganisms can beachieved also by means of elicitor-containing fungi andyeasts such as listed in Table 1.
Using cell wall preparations of microorganisms listed inTable 2 it was also possible to obtain a significantincrease in alkaloid formation in cell cultures of higherplants,, such as Eschscholtzia californica or Rauvolfiaserpentina- It was also possible using those cell wall preparationssignificantly to enhance the capacity of Bacillus lentusto dehydrogenate steroids in the 1,,2-position and thecapacity of Rhodotorula glutinis to reduce 17-ketosteroids selectively and the capacity of Penicillin®raistrickii to hydroxylate steroids in the l5a-position.Hitherto, only the attempt to enhance the capacity ofCurvularia lunata to hydroxylate steroids in the 118" 8 position using those cell wall preparations has beenunsuccessful- Those tests appear to justify the hope that it will bepossible using the method according to the invention also 5 to stimulate the formation of numerous other industrially applicable microbial components and to enhance otherenzyme activities of microorganisms that are susceptibleof industrial application» Such microbial components are, for example, antibiotics, 10 such as the penicillins, cephalosporins, cyclosporins, actinomycins, gramicidins, neomycins, geataaycins,nystatins, tetracyclines, nicomycins or lincomvcin,erythromycin, chloramphenicol, griseofulvin or fusidicacid, inter ajJLa, ergot alkaloids, such as ergocryptine, 15 ergotamine, ergosine, ergocristine, ergooomine, agro- clavin, chanoclavin, festuclavin, paspalic acid, orlysergic acid derivatives, vitamins, sues as vitamin B12, riboflavin or fi-carotene, enzymes, such as theamylases, glucose isomerases, proteases, pectinases, 20 cellulases, lipases, penicillin acylases, chitinase or lactase, nucleosides, such as guanylic acid or inosylicacid or, for example, also amino acids, such as cysteine,glutamic acid, tryptophan or lysine.
It should in principle also toe possible to enhance the 25 endogenous or exogenous protein formation of genetically modified microorganisms. Such useful proteins are notonly the enzymes and antibiotics already mentioned butalso, for example, interferon, insulin, erythropoietinand TNF. 30 Microorganisms that are used industrially owing to their enzyme activities are described, for example, in the following publications^ 9 W. Charney and H. Herzog: Microbial Transformations ofSteroidsj Academic Press, Kew York etc. 1967K. Kieslich: Microbial Transformations of Hon-steroidalCyclic Compounds; Georg Thieiae Publ. Stuttgart (Germany),, 5 1976 and K. Kieslich: Biotransf oraations ? in H.J. Rehm and G. Reed(editors): Biotechnology; Weinheim (Germany) etc. V©1. 6a, 1984.
Such microorganisms are, inter &li&, those which bring10 about steroid transformations such as 11α-, I IS- or 15c- hydroxylation, Aj-dehydrogenatien, 17c-, X7£-keto reduc-tions or the side chain decomposition of sterols ortransformations' of antibiotics, such as penicillincleavage. '5 It is not improbable that it would be possible using themethod according to the invention to find new indus-trially utilisable microbial components, such ase forexample, new antibiotics, by adding inactive elicitor-containing microorganisms to the microorganisms to be 20 tested. That hope is not without foundation because it isknown that numerous higher plants form phytoalexins inappreciable quantities only when they are infected withelicitor-containing raxcroorganisms.
Conventional methods familiar to the person skilled in 25 the art are used to determine what eliciter-containingmicroorganism enhances the enzyme activities or the synthetic capacity of a specific microorganism.
It is not difficult for the person skilled in the art to 30 carry out the method according to the invention as far a® fermentation by means of microorganisms is concerned.The microorganism the en2yme activity or the syntheticcapacity of which is to be enhanced is grown under the 10 known conditions; the inactivated elicitor-containingmicroorganisms, fragments of the same, cell extracts ofthe saxe or secretions of the same are then added to theculture and fermentation is continued in the customary 5 nanner. The addition of the inactivated microorganisms, the fragments or extracts of those higher plants or thesecretions of elicitor-containing microorganisms can heeffected at the beginning of the fermentation process.
The optiwuaa time for addition naturally depends on the 10 type of microorganism grown, especially on the course of its 'exponential growth phase, and must be determined ineach individual case. For example, it often provesadvantageous in the case of bacteria to effect theaddition from 4 to 30 hours after the commencement of 15 fermentation. In the case of the addition of inactivated Microorganisms or fragments of the same, from l to 1000 g(preferably from 10 to 200 g) of inactivated micro-organise or from 0J to 100 g (preferably from 1 to 30 g)of the fragment of that organism are customarily used per 20 j cubic wetre of fermentation broth. If secretions of elicitor-containing microorganisms are used, it willgenerally be sufficient to use from 1 to 50 litres of thesecretion solution per cubic metre of fermentationvolume- If the method according to the invention is used 2 5 to enhance the enzyme activity of a microorganism used for the enzymatic conversion of substrates, the additionof the substrate will generally he started from 0 to 10hours after the addition of the elicitor-containinginactivated microorganism or its fragments or secretions - 30 ψΐιβ optimum fermentation conditions depend on the type of microorganism used, the nutrient medium used, thefermentation time, the type and amount of the elicitor-contaxning material etc; they have to he determined ineach individual case by preliminary tests such as are 35 familiar to the person skilled in the art.
IX For the preparation of the inactivated elicitor-contain-ing microorganisms, the latter are grown under customaryconditions j, then separated from the culture medium bycentrifugation or filtration, if desired washed andisolated again. Various processes can be used to inactiv-ate the microorganisms.
Possible methods of inactivation consist in causingtypical substances lethal to cells, such as ethyleneoxides, formaldehyde, ©sons, mercury compounds or organicsolvents, such as methanol, ethanol or acetone, to act onthe microorganisms or in killing the microorganisms byheating to from 90"C to 140"c, by the influence ofextreme pressure differences (disintegration), the actionof high-frequency electric fields or by UV irradiation,irradiation with V-rays or the action of ultrasound. Theconditions under which inactivation can be carried outare well known to the person skilled in the art (K.H.Wallhauser, H. Schmidt: Sterilisation, Desinfektion,Konservierung, Chemotherapie, Georg Thierae Verlag,Stuttgart (Germany), 1967).
Fragments of elicitor-containing microorganisms can beobtained, for example, by lysis of the microorganisms bythe action of osmotic shock or temperature shock, byautolysis of the microorganisms, by treatment of thecells with ultrasound or by trituration of the micro-organisms with glass beads, powdered glass or quartzsand followed by differential centrifugation (Hughes, D.E., Wimpenny, J.W.T. and Lloyd, 0.: The disintegrationof micro-organisms. In: Methods in Microbiology, Vol. 13,(Norris, d.R. and Ribbons, D.W., eds.) pp. 1-54, AcademicPress, New York, London, 1971).
Purified cell wall fractions can be obtained from those 12 cell fragmentst for example,, by trypsin treatment. Thecell wall fractions already mentioned and used in thefollowing worked Examples were prepared in accordancewith the method described by Schleifer and Kandler (Arch.Mxkrobiol. §7, 1967, 335-365).
On the other hand, it is, however, also possible toprepare elxcitor-containing precipitates from water-soluble cell constituents by precipitation, for examplewith ethanol or acetone (Kocourek, J- and Ballou, C.S., J. Bacterial. 100, 1969, 1175-1181).
Secretions of el icitor-containing microorganisms areactively released cell constituents obtained by lysing, making "leaky", extracting with supercritical liquefiedgases (for example carbon dioxide) or heat-sterilising cells in water, water-soluble culture media, or culture media obtained by removing the microorganisms and higher plants by filtration or centrifugation. These can, ifnecessary, be further purified, for example by extractionof lipophilic substances, adsorption of strongly colour-ing substances, etc..
It has already been mentioned that the use of enzyme-freeelicitor-containing material from bacteria to enhance thesynthetic capacity of components of higher plants hasbeen demonstrated experimentally; this could be ofimportance for the use of plant cell cultures in thepreparation of the active ingredients of medicaments(M.H. Zenk in: Pharmazie heute, 103. 1982, Volume 3,131-138).
The following worked Examples serve to illustrate theinvention in detail. 13 Example. 1 Stimulation of the synthesis of coloured components(actinorhodin, prodigiosin) in the case of Streptomyceslividans (ATCC 1S344) hv cell wall preparations. 80 ml of a nutrient medium comprising 103 g 10 g 10 ..,12 g0.25 g0.1 g 800 ml saccharose glucose magnesium chloride hexahydrate potassium sulphate casamino acids (Difco Labs, Detroit/USA)distilled water are sterilised (20 minutes, 120'C) and supplemented understerile conditions with the following freshly preparedsolutions. 1 ml 0.5 % potassium dihydrogen phosphate solution 8 ml 3.68 % calcium chloride dihydrate solution 1.5 ml 20 % L-proline solution 10 ml 5.73 % TES buffer solution (pH 7.2) 0.2 ml trace element solution - containing per 1 itre 40 mg 2inc(II) chloride 200 mg iron(III) chloride hexahydrate10 mg copper (XX) chloride dihydrate10 mg manganese ( XI) chloride tetrahydrate10 mg disodium tetraborate dihydrate10 mg hexaasraionium heptamolybdate tetrahydrate 0.5 ml IN sodium hydroxide solution 1.8 ml of that nutrient solution are introduced under 14 sterile conditions into each of the 24 3-sal-capacitychambers of a polystyrene multidish 'Multidish„ manufac-tured by Nunc, S200 Wiesbaden 12). 2 mg of the cell wallpreparations to be tested for their elicitor content arestex’ilised for 20 minutes at 120'C in bi-distilled waterand the resulting suspensions are added to the chambers. 2 Chambers receive no additions and are used as controls-The volume in all the chambers is Uoniformly adjusted to2 ml with bi-distxlled water under sterile conditions.Each chamber is inoculated identically with 5 μΐ of aspore suspension of Streptcmyces lividans (ATCC 19844).The test batch is incubated under aerobic conditions(Tablar shaker; 100 revolutions per minute) at 26"C.
After 96 hours,, the cells are isolated by centrifugation,washed with physiological saline solution and dried invacuo over calcium chloride to give the cell yieldslisted in the Table. The supernatants obtained bycentrifugation are adjusted to a pH of 7, diluted to 4 mlwith water and their absorption spectra are determinedbetween 180 and 800 nm. The relative amounts of thesynthesised dissolved secondary substances act i nor hod inand prodigiosin are determined approximately by assessingthe absorption peaks of the spectra recorded automatical-ly.
The following Table 3 shows the results obtained in thattest series. 15 TABUS 3 Tested bacterial cell walls of dry cell yield (mg) dyestuff content rel. absorp __txon units without (control) 22 1 B. ammoniagenes (ATCC 6872) 25 38 B„ glutasiingenes (ATCC 13747) 32 24 Ba. pumilus (ATCC 7061) 34 2 B. linens (ATCC 19391) 23 1 c, diphtherias (Mass. 8) 24 34 C- saelassecola (ATCC 17965) 26 34 C. glutamicum (ATCC 13032) 43 50 C. lilium (ATCC 15990) 33 40 Ce. cellassa (ATCC 14359) 36 2 L. piantarum (DSM 20174) 32 31 S. aureus strain H 44 1 B = Brevibacterium Ba = Bacillus C = Corynebacterium Ce = Cellulosnonas L = Lactobacillus S = Staphylococcus Example 2 Stimulation of the synthesis of coloured components(actinorhodin, prodigiosin) in the case of Streptomyceslivxdans (ATCC 19844) by cell wall extracts.
Under the conditions of Example lf but using the sterilefiltrates of the 2-rag cell wall preparations sterilisedfor 20 minutes at 120eC in bi"distilled water, a stimula- tian of dyestuff formation is achieved in Streptomyceslividans (ATCC 19844) that is almost as strong as whenusing suspensions of those sterilised cell walls.
...J Stimulation of the synthesis of coloured components(actinorhodin, prodigiosin) in the case of Streptomyceslividans (ATCC 19844) by cell extracts.· Under the conditions of Example 2, but using 20 mg ofbiomass instead of 2 mg of cell wall preparation, astimulation of dyestuff formation is achieved that isapproximately equally as strong as when using suspensionsof the sterilised cell walls. gj£§BSig__4 Stimulation of the synthesis of coloured components inthe case of Streptomyces coelicolor A3(2) or (ATCC 13405).
Under the conditions of Example 1, but using Streptomycescoelicolor A3(2), a marked stimulation of dyestuffformation (probably likewise actinorhodin) is achieved inthe case of this bacterium.
Stimulation of the synthesis of coloured components inthe case of Streptomyces griseoruber (DSH 40275).
Under the conditions of Example 1, but using Streptomycesgriseoruber (DSH 40275), a very marked increase indyestuff formation (presumably anthracvclin antibiotics)is achieved in the case of this bacterium also. 17 EMsaalS-A Stimulation of the synthesis of coloured components inthe case of Streptomyces purpurascens (DSH 40 310), Under the conditions of Example 1, but using Streptomyces5 purpurascens (DSH 40 310), a distinct increase in dyestuff formation (presumably likewise anthracyclinantibiotics) is achieved in the case of this bacteriumalso, Ε2£δΒΚΐ£_Ζ 10 Stimulation of the synthesis of coloured components inthe case of Streptomyces latericius (DSH 40 163).
Under the conditions of Example 1, but using Streptomyceslatericius (DSH 40 163), a significant increase indyestuff formation is achieved in the case of this bac- 15 terium also.
Example-.¾ Stimulation of the synthesis of coloured components inthe case of Streptomyces violaceus (DSH 40 082), Under the conditions of Example 1, but using Streptomyces20 violaceus (DSH 40 082), a significant increase in dyestuff formation is achieved in the case of thisbacterium also. 18 Example 9 Stimulation of the formation of B-lactam antibiotics(cephalosporins, penicillin K) by Streptomyces clavuli-gerus (ATCC 27064). 5 g 3-(M-morpholino)-propanesulphonic acid (MOPS) 3.5 g .dipotassium hydrogen phosphate0.5 g magnesium sulphate heptahydrate 2 g L~aspsragin@ 10 g glycerol 1 g yeast extract (Oxxd, Wesel, Germany) 1 ml trace element salt solution ~ containing per litre 1 g iron(II) sulphate heptahydrate1 g manganese(II) chloride tetrahydrate1 g zinc chloride heptahydratel g calcium chloride are wade up to 1 litre with distilled water and sterili-sed (20 minutes; 120'"c) . 1.8 ml of that nutrient solution are introduced understerile conditions into each of the 3-ml~capacitychambers of a sterile polystyrene multidish (Multidish;manufactured by Munc, 52 Hiesbaden 12). 2 mg of the cellwall preparations to be tested for elicitor activity or10 mg of the cells to be tested are added in the form ofhomogeneous suspensions sterilised in bi-distilled water(20 and 45 minutes, respectively, 120"C). Two chambersserving as control receive no additions. The volume inall the chambers is then uniformly adjusted to 2 ml withbi-distilled water under sterile conditions. Each chamberis inoculated identically with 5 μΐ of a spore suspensionof Streptomyces clavuligerus (ATCC 27064).
The incubation of the test series is carried out under 19 aerobic conditions (Tablar shaker? 160 revolutions perminute) at 26 "C. The incubation time is from 24 to 48hours.
The formation of antibiotics is examined in comparisonwith the controls using the plate diffusion test» Thedetector organisms suspended in soft nutrient agar areMicrococcus luteus and Bacillus subtilis (106 cells perml). 25 μΐ of centrifuged (48,000 x g) culture mediumfrom the test chambers are applied to each ©f a number ofstandard filter plates (0,9 cm diameter). After adiffusion time of 4 hours at 4*C, the biotest is incub-ated for 24 hours at 30’c.
In the case of the cultures that were grown with theaddition of killed cells of Brevibacterium flavum ATCC13826 or of cell wall preparations of that bacterium orof cell wall preparations of Corynebacterium diphtherias(strain Mass. 8), clearly enlarged inhibiting areolasexhibited an increased formation of B-lactam antibiotics(penicillin M, cephalosporins) by streptomyces clavuli-gerus compared with the controls.
Exajaale-IO Stimulation of the formation of alkaloids (sanguinarine,chelirubine, marcarpine and chelerythrine) by cultures ofEschscholtzia califarnica - Tissue cultures of Eschscholtzia californica are grown ineach of 24 1-ral chambers of a polystyrene multidish(manufactured by Nunc, 6200 Wiesbaden 12) under theconditions described as optimum by J. Berlin e,t a_l. (Z.Naturforsch., 38c, 1983, 346-352). One of the chambersdoes not receive any further additions and is used as thecontrol, one chamber receives 266 rag/1 of heat-extracted 20 and ethanol-precipitated yeast elicitor (prepared inaccordance with Kocourek J. and Balleu„ C.E. „ J- Bacter-ial Iflfii, 1969, 1175-1181), and the others each receive266 mg/1 of cell wall preparation of the bacteria listedin Table 3. The cultures are then incubated for 72 hoursat 24 "C and then the alkaloid content of the cultures isdetermined photometrically, the alkaloid content inducedby the yeast elicitor being evaluated as 100 %.
Table 4 below shows the results obtained in this test series. TABLE 4 Tested bacterial cell walls % elicitor activi£v Brevibacterium butanicus ATCC 21196 19 Brevibacterium flavum ATCC 13826 16 Brevibacterium flavum ATCC 14067 30 Brevibacterium glutamingenes ATCC 137 113 Brevibacterium lactofermentum ATCC 13655 43 Brevibacterium ammoniagenes ATCC 6872 40 Corynebacterium hydrocarboclastum ATCC 15592 8 Corynebacterium nephridii ATCC 11425 123 Corynebacterium paurometabolum ATCC 8368 16 Corynebacterium liliua ATCC 15990 108 Corynebacterium striatum ATCC 6940 17 Corynebacterium petrophilum ATCC 19080 0 Corynebacterium xerosis ATCC 373 102 Corynebacterium diphtherias strain Mass. 8 137 Rhodococcus fascians ATCC 12975 27 Rhodococcus fascians 1 11 isolate of Prof. Dr. Stolp* Univ. Bayreuth Rhodococcus fascians 2 isolate of. Prof... -Dr Qni,y^ ftavEeush. 21 Exafflels-ll Stimulation of the formation of indole alkaloids (valles-iacotaaine) in cultures of Rauvolfia serpentina. A suspension culture of Rauvolfia serpentina (Stockist, J., A. Pfitzner and J. Firl: Plant Cell Rep. 1, 36-39(1981) is cultivated in ULnsmaier and Skoog (LS)-medium(Physiol. Plantaruis 18. 100-127 (1965) en rotary shakers(100 revolutions per minute) at 23 "C vith permanentlight (6Θ0 lux). For elicitation# 200 g of call freshveight/1 LS medium are inoculated. Cell wall preparationsof the bacteria listed in Table 4 are used at a concen-tration of 130 mg/1 medium as elicitor-containingfragments of microorganisms.
After 5 days' incubation, the biomass has doubled both inthe elicited cultures and in the controls. The cells areharvested and extracted with methanol.
The amount of the indole alkaloid vallesiacotamine is determined by separating the extracts by HPLC. Whereasthe untreated control cultures contain only 1.16 mg/1 ofmedium, the yield in the case of the elicited cultures isa maximum of 58 mg/1. That corresponds to a 50-foldincrease by the elicitor.
Sxa®aia=ia Stimulation of the 17-keto steroid reductase activity ofRhodotorula glutinis XFO 0389. a) A 2-litre Srlenmeyer flask with. 500 ml of sterilenutrient medium containing5 % glucose monohydrate 22 2 % cornsteep liquor - adjusted to pH 6.5 - is inoculated with a smear from a slant agarculture of Rhodotorula glutinis IF0 0389 andcultivated for 40 hours at 30" C and. at 190 revolu-tions per minute. b) A SOO-ni Erlenmeyer flask with 100 ml of sterilenutrient aieditm containing 1 % corasteep liquor 5 % Hurupan (R) (aanufacturer Murupan GnbK, 4000DQsseldorf 1? Gerssany) 1 % Hetarin W (manufacturer Lucas Meyer; 2000 Hamburg 2S; Genaany) - adjusted to pH 6.2 - is inoculated with 10 ml of the Rhodotorula pre-culture prepared in accordance with Example 12a andcultivated for 7 hours at 30"C and 180 revolutionsper minute . 10 mg of 3-hydraxy-l, 3,5( 10) ,7~oestratetraen-17-oneare then added to the culture and fermentation iseffected for a further 210 hours. The culture isthen extracted with methyl isobutyl ketone, theextract is concentrated and the resulting crudeproduct is purified by chromatography on a silicagel column to yield 5.9 mg of 1,3,5( 10) ,7-oestra-tetraene-3„ 17a~diol = 59 % of the theoretical yield. c) 10 mg of 3-hydroxy-l, 3,5 (10), 7-oestratetraen- 17-one are fermented with a culture of Rhodotox-ula glutinisunder the conditions of Example 12b except that 5 mlof a sterile suspension of 50 mg of a cell wallpreparation of Bacillus licheniforssis (ATCC 9945) inwater are added to the culture immediately beforethe addition of the substrate. After working up the 23 culture, 6.8 mg of 1,3,5(10),7"oestratetraene-3,17-diole = 68 % of the theoretical yield are obtained. £KawlS_U.
Stiaulation of the steroid Δχ-dehydrase activity of5 Bacillus lentus (ATCC 13805). a) A 2-litre Erleimeyer flask with 500 al of sterilenutrient solution containing0.5 % cornsteep liquor Q.05 % glucose nonohydrate0.1 % yeast extract ~ adjusted to pS 7.0 - is inoculated with a rinse of Bacillus lentus (ATCC13 805) and shaken for 48 hours at 30'c and at 190revolutions per minute. 20 25 30 b) A SQO-ffnl Erleruaeyer flask with 100 sal of sterilenutrient solution containing3.0 % soya powder 0.5 % cornsteep liquor 0.1 % yeast extract 0.05 % glucose raonohydrate~ adjusted to pH 7.3 - is inoculated with 10 ml of the Bacillus lentuspreculture and shaken for 7 hours at 30"C and at 180revolutions per minute. A sterile-filtered solutionof 40 sa of Se^a-dif luoro-llB^lVe-dihydroxy-ieffi-methyl-'J-pregnene-l ,20-dione in 4 ml of dimethyl-formamide is then added to the culture and the wholeis incubated for a further 41 hours.
The culture is then extracted with methyl isobutylketone, the extract is concentrated in vacuo andthe residue is purified by chromatography on a 24 silica gel column to yield 16 sg of 6cf9c:~dii luoro-1XB,17a-dihydroxy"16c-methyl-l „ 4-pregnadiene-3,20-dione (= 40 % of the theoretical yield)» c) 40 mg of 6ci,9G-difluoro-llBl)17G-dihydroxy-l6G" methyl-4-pregnene-3,20-dione are fermented with aculture of Bacillus lentus under the conditions of Example 13b except that 5 al of a sterile suspensionof 50 mg of cell wall preparation of Corynebacteriumdiphtherias (strain Mass» 8) in water are added tothe culture immediately before the addition of the substrate. After working up the culture, 21 mg of Se e 9®-dif luora-llfi g I7c-dihydroxy»16ec-methyl-i , 4-pregnadiene~3»2G~dione (= 52.5 % of the theoretical yield) are obtained. S3£3JiEl£_ll Stimulation of the formation of alkaloids (lysergic acidamide and isolysergic acid amide) by Claviceps paspali(ATCC 13895). a) A 500-ml Erlenmever flask with 50 ml of a starilanutrient solution containing4 % sorbitol (industrially pure) 1 % glucose monohydrate 2 % succinic acid 0.6 % ammonium sulphate 0.5 % yeast extract (Difco(^) manufactured tv Difco Labs. Detroit/USA) 0.1 % potassium dihydrogen phosphate 0.03 % magnesium sulphate heptahydrate-adjusted to pH 5.2 with sodium hydroxide solution-is inoculated with a culture of Claviceps paspali(ATCC 13895) deep-frozen to -70‘c and shaken for 5days at 24’C and 240 revolutions per minute. 25 10 15 b) A 500"®l Erlenmeyer flask with 50 sal of a sterilenutrient solution containing3 t sorbitol (industrially pure) δ % succinic acid 0-9 % ammonium sulphate 0.1 i calciua nitrate tetrahydrate 0.05 % dipotassiu® hydrogen phosphate 0.03 ϊ magnesium sulphate heptahydrate 0.02 t yeast extract (Difc©^ manufactured by Difco Labs., Detroit/USA) 0.0007 % iron(II) sulphate heptahydrate0.0QQ6 % zinc sulphate heptahydrate-adjusted to pH 5.2 with sodium hydroxide solution-is inoculated with 5 si of a pre-culture of Clavi-ceps paspali and shaken for 250 hours at 24’c and at240 revolutions per minute.
Sufficient sodium hydroxide solution is then added to the culture to adjust the pH to at least 10,extraction is carried out with «ethyl isobutylketone and the extracts are concentrated in yasna and purified by chromatography on a silica gelcolunn. 35 rag of a mixture of lysergic acid aside andisolysergic acid amide (yield 700 sag/I of culture) 25 are thus obtained. c) A culture of Claviceps paspali is grown under theconditions of Example 14b except that 5 ml of asterile suspension of 25 rag of cell wall prepara-tion of Lactobacillus casei subsp. rhawraosus (ATCC 30 7469) in water are added to the culture after 72 hours. After working up the culture# 45 rag of amixture of lysergic acid amide and isolysergic acid 26 amide (yield 900 sag/1 of culture) are obtained.
Exassls-U Stimulation of the 15e-hydroxylase activity of Penicil-lin® raistrickii (ATC'C 10490). a) A 2-litre Erlennever flask with 500 al of sterilenutrient aediua containing 3 % glucose aoncfcydrate 1 % eornsteep liquor 0.2 % sodiuE nitrate 0.05 % magnesia» sulphate heptahvdrate 0.05 t potassium chloride0.002 % iron(II) sulphate hexahydrate0., 1 * potassium dihydrogen phosphate 0.2 i dipotassiua hydrogen phosphate - adjusted to pK 6.0 - is inoculated with a suear from a slant agarculture of Penicilliuia raistrickii (ATCC 1G490) andcultivated for 48 hours at 30 "c and at 180 revolu-tions per ainute. b) A 500—331 Erlenmeyer flask with 100 ml of sterilenutrient medium containing 1 1 cornsteep liquor 3 % glucose monohydrate 0.1 § potassium dihydrogen phosphate 0.2 % dipotassiu® hydrogen phosphate 0.05 % magnesium sulphate heptahydrate - adjusted to pH 6.0 - 27 is inoculated with 10 ml of the Penicillium pre-culture prepared in accordance with a)« 300 sag of l3~ethyl-4-gonene-3,17-dione are thenadded to the culture and the whole is fernented for 5 120 hours at 30 "c and at 180 revolutions per minute.
The culture is then extracted with methyl isobutvlketone, the extract is concentrated and the result-ing credos product is purified toy chroaatography ona silica gel column to yield ISO ag of 13-ethyl-15c- 10 hydroxy-4-gonene-3,17-dione. c) 300 mg of 13-ethyl-4~gonene-3,17-d£one are fermentedwith a culture of Penicillium raistrickii under theconditions of b) except that 5 ml of a sterilesuspension containing 50 mg of a call wall prepara- 15 tion of Corynebacteriua diphtheria® (strain Hass- 8) in water are added to the culture issBediaeelybefore the addition of the substrate- After workingup the culture, 210 mg of 13-efchyl—15c-hydroxy~4-gomene-3,17-dione are obtained.
Claims (7)
1. Method of enhancing enzyme activities and the syn-thetic capacity of microorganisms and higher plants,characterised in that the same are brought into contactwith inactivated elicitor-containing nicroorganisus ,fragments of the same or secretions of elicitor-contain-ing microorganisms, with the proviso that, in order toenhance enzyme activities and the synthetic capacity ofhigher plants, inactivated elicitor-cemtaining bacteria,fragments of the same or secretions of elicitor-contain-ing bacteria are used.
2. Method of enhancing enzyme activities and the syn-thetic capacity of microorganisms according to patentclaim 1, characterised in that the same are brought intocontact with inactivated elicitor-containing micro-organisms , fragments of the same or secretions ofelicitor-containing microorganisms»
3. , Method of enhancing the synthetic capacity of nicro-organisns according to patent claim 2, characterised inthat bacteria, fungi and yeasts capable of formingdyestuffs, alkaloids or antibiotics are brought intocontact with inactivated elicitor-containing bacteria,fungi or yeasts, fragments of the same or secretions ofthose microorganisms,.
4. Method of enhancing enzyme activities of micro-organisms according to patent claim 2, characterised inthat bacteria, fungi or yeasts capable of steroidtransformation are brought into contact with inactivatedclicitor-containing bacteria, fungi or yeasts, fragmentsof the same or secretions of those microorganisms.
5. Method of enhancing the synthetic capacity of higher 29 plants according to patent claim 1, characterised inthat cell cultures off higher plants capable off dyestuff synthesis, alkaloid synthesis or phytoalexin synthesisare brought into contact with inactivated elicitor- 5 containing bacteria, fragments of the same or secretions of those bacteria.
6. , Method off enhancing enzyme activities and the syn-thetic capacity of microorganisms and higher plantsaccording to patent claims 1 to 5, characterised in that 8 0 the same are brought into contact with elicitor-contain-ing microorganism» heat-sterilised in water, or withfiltrates of the same.
7. , A 'taechod subscatttiaily as hereinbefore describedwich reference to the Examples. Dated this 1 3 eh day of January 1989 CRCICKSKABK δ CO. Agents for the Applicant 1 Holies Street Dublin 2
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3801023A DE3801023A1 (en) | 1988-01-13 | 1988-01-13 | METHOD FOR INCREASING ENZYME ACTIVITIES AND THE SYNTHETIC PERFORMANCE OF ORGANISMS |
Publications (2)
Publication Number | Publication Date |
---|---|
IE890079L IE890079L (en) | 1989-07-13 |
IE66500B1 true IE66500B1 (en) | 1996-01-10 |
Family
ID=6345349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE7989A IE66500B1 (en) | 1988-01-13 | 1989-01-13 | Method for increasing enzyme activities and synthesis performance of organisms |
Country Status (19)
Country | Link |
---|---|
EP (2) | EP0354945B1 (en) |
JP (1) | JPH02502881A (en) |
CN (1) | CN1034756A (en) |
AT (1) | ATE103325T1 (en) |
AU (2) | AU3215989A (en) |
BG (1) | BG60596B1 (en) |
CA (1) | CA1317247C (en) |
DD (1) | DD278357A5 (en) |
DE (2) | DE3801023A1 (en) |
DK (1) | DK442289A (en) |
ES (1) | ES2051894T3 (en) |
FI (1) | FI97302C (en) |
HU (1) | HU208341B (en) |
IE (1) | IE66500B1 (en) |
IL (1) | IL88953A (en) |
NO (1) | NO893643L (en) |
PT (1) | PT89427B (en) |
WO (1) | WO1989006687A1 (en) |
ZA (1) | ZA89304B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7264951B1 (en) | 1992-02-20 | 2007-09-04 | Phyton, Inc. | Enhanced production of taxol and taxanes by cell cultures of Taxus species |
KR20100070388A (en) | 1996-05-24 | 2010-06-25 | 디에프비 바이오테크 인코포레이티드 | Enhanced production of taxanes by cell cultures of taxus species |
GB9611089D0 (en) | 1996-05-28 | 1996-07-31 | Sandoz Ltd | Organic compounds |
US10749991B2 (en) | 2017-05-31 | 2020-08-18 | Regents Of The University Of Minnesota | Emulation-based cross-technology communication |
CN107746849B (en) * | 2017-09-29 | 2022-01-18 | 天津科技大学 | Efficient screening method of steroid hydroxylase genes |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1259938A (en) * | 1985-12-05 | 1989-09-26 | Friedrich Constabel | Repeated elicitor treatment, a method for semicontinuous metabolite production by plant cells cultured in vitro |
-
1988
- 1988-01-13 DE DE3801023A patent/DE3801023A1/en not_active Withdrawn
-
1989
- 1989-01-11 EP EP89901715A patent/EP0354945B1/en not_active Expired - Lifetime
- 1989-01-11 ES ES89100337T patent/ES2051894T3/en not_active Expired - Lifetime
- 1989-01-11 HU HU89975A patent/HU208341B/en not_active IP Right Cessation
- 1989-01-11 AT AT89901715T patent/ATE103325T1/en not_active IP Right Cessation
- 1989-01-11 EP EP89100337A patent/EP0325933B1/en not_active Expired - Lifetime
- 1989-01-11 AU AU32159/89A patent/AU3215989A/en not_active Abandoned
- 1989-01-11 WO PCT/EP1989/000015 patent/WO1989006687A1/en active IP Right Grant
- 1989-01-11 DE DE89901715T patent/DE58907274D1/en not_active Expired - Lifetime
- 1989-01-11 DD DD32499389A patent/DD278357A5/en not_active IP Right Cessation
- 1989-01-11 JP JP1501513A patent/JPH02502881A/en active Pending
- 1989-01-12 PT PT89427A patent/PT89427B/en not_active IP Right Cessation
- 1989-01-12 CA CA000588110A patent/CA1317247C/en not_active Expired - Fee Related
- 1989-01-13 IL IL8895389A patent/IL88953A/en not_active IP Right Cessation
- 1989-01-13 IE IE7989A patent/IE66500B1/en not_active IP Right Cessation
- 1989-01-13 CN CN89100184A patent/CN1034756A/en active Pending
- 1989-01-13 ZA ZA89304A patent/ZA89304B/en unknown
- 1989-09-07 DK DK442289A patent/DK442289A/en not_active Application Discontinuation
- 1989-09-12 NO NO89893643A patent/NO893643L/en unknown
- 1989-09-12 FI FI894304A patent/FI97302C/en not_active IP Right Cessation
- 1989-09-13 BG BG89739A patent/BG60596B1/en unknown
-
1992
- 1992-11-05 AU AU28183/92A patent/AU2818392A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA1317247C (en) | 1993-05-04 |
ES2051894T3 (en) | 1994-07-01 |
AU3215989A (en) | 1989-08-11 |
IE890079L (en) | 1989-07-13 |
HU208341B (en) | 1993-09-28 |
NO893643D0 (en) | 1989-09-12 |
PT89427B (en) | 1993-09-30 |
PT89427A (en) | 1990-02-08 |
ATE103325T1 (en) | 1994-04-15 |
DD278357A5 (en) | 1990-05-02 |
DE3801023A1 (en) | 1989-07-27 |
EP0325933A1 (en) | 1989-08-02 |
ZA89304B (en) | 1989-10-25 |
IL88953A0 (en) | 1989-08-15 |
FI97302B (en) | 1996-08-15 |
BG89739A (en) | 1993-12-24 |
NO893643L (en) | 1989-09-12 |
HUT57270A (en) | 1991-11-28 |
JPH02502881A (en) | 1990-09-13 |
EP0354945B1 (en) | 1994-03-23 |
DK442289D0 (en) | 1989-09-07 |
FI97302C (en) | 1996-11-25 |
DK442289A (en) | 1989-09-07 |
WO1989006687A1 (en) | 1989-07-27 |
IL88953A (en) | 1995-03-30 |
EP0325933B1 (en) | 1994-03-09 |
CN1034756A (en) | 1989-08-16 |
AU2818392A (en) | 1993-01-14 |
FI894304A0 (en) | 1989-09-12 |
BG60596B1 (en) | 1995-09-29 |
DE58907274D1 (en) | 1994-04-28 |
EP0354945A1 (en) | 1990-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Takeuchi et al. | Monoamine oxidase inhibitors isolated from fermented broths | |
Murao et al. | Isolation of amylase inhibitor-producing microorganism | |
IE66500B1 (en) | Method for increasing enzyme activities and synthesis performance of organisms | |
US4729951A (en) | Process for the improvement of antibiotic production by in vivo genetic recombination | |
Evidente et al. | Degradation of lycorine by Pseudomonas species strain ITM 311 | |
US4870172A (en) | Bisucaberin | |
HU181488B (en) | Process for the hydrolysis of racemic hydantoins into optically active n-carbamoyl-aminoacid derivatives and for preparing the hydrolyzing enzymatic complex | |
WO1995034558A1 (en) | Chondramides, production methods, compositions comprising chondramides and cultures for chondramide production | |
Skotnicki et al. | Bacterial and bacteroid properties of mutants of Rhizobium trifolii strain T1 uncoupled in oxidative phosphorylation | |
CA1193211A (en) | Process for producing mitomycin a by fermentation | |
US3598819A (en) | Quinoxaline derivatives and process for producing the same | |
OCHI et al. | Physiological analysis of bicozamycin high-producing Streptomyces griseoflavus used at industrial level | |
USRE29163E (en) | 1,2,3,4,10,19-Hexanor-9-oxo-5,9-seco-25D-spirostan-5-oic acid | |
JPS5920359B2 (en) | Production method of polylysine | |
US4992570A (en) | UCN-1028A and UCN-1028C and process for the production thereof | |
Sunahara et al. | Production of xanthine oxidase inhibitor, 2, 8-dihydroxyadenine, by Alcaligenes aquamarinus | |
US3634461A (en) | Spirostan derivative | |
JPH0625277A (en) | Bacterium producing novel testosterone-5alpha-reductase-inhibiting substance, sna-4606, novel testosterone-5-reductase-inhibiting substance, sna-4606 and its production | |
JPS61289898A (en) | Production of factor for suppressing sporulation of phytopathogenic fungus | |
JPS61289005A (en) | Plant pathogenic germ sporulation inhibitor | |
US2951016A (en) | Process for the manufacture of delta1, 4-steroids | |
US3923601A (en) | Process for the manufacture of cephalosphorin C | |
Sheridan et al. | Stereoselective reduction of radicinin by liquid cultures of Alternaria longipes | |
JPS5959198A (en) | Novel preparation of antibiotic neoviridogriseins | |
Maeda et al. | Identification of nicotine-1′-N-oxide degrading bacteria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed |